Kedar Kirtane, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Travel
    Ineligible company:
    A2Bio Therapeutics
    Topic:
    CAR-T for Solid Tumors
    Date added:
    05/04/2023
    Date updated:
    05/04/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Seattle Genetics
    Date added:
    05/04/2023
    Date updated:
    05/04/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Oncternal Therapeutics
    Date added:
    05/04/2023
    Date updated:
    05/04/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Shockwave Medical
    Date added:
    05/04/2023
    Date updated:
    05/04/2023
Return to Seattle Cellular Therapy Summit: Patient-Centered Approach to Improve Outcomes